AbbVie is a global biopharmaceutical company whose corporate strategic venture capital arm, AbbVie Ventures, invests in novel, transformational therapeutics at discovery and pre-clinical stages. AbbVie Ventures focuses on early-stage opportunities in oncology, immunology, neuroscience, eye care, and aesthetics, investing the parent company's capital since 2009.
55% of their portfolio is in Biotech & Life Sciences. Their most common stage is series-a (42% of deals). Average disclosed round size is $65.8M (across 24 rounds with reported amounts).
Portfolio
26
Fund Size
—
Top Stage
Series A
Last 12 Mo
1
Team
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
33 investments
| Company | Round | Amount | Date |
|---|---|---|---|
| SSoufflé Therapeutics | Series A | — | Aug 2026 |
 ThirtyFiveBio Limited | Bridge | — | Apr 2025 |
 Accent Therapeutics | Series C | $75M | Jan 2024 |
 Nitrase Therapeutics | Series A | $45M | Nov 2021 |
| RRibon | Series B | $65M | Jul 2021 |
| KKojin Therapeutics | Series A | $60M | Jun 2021 |
| CCarisma Therapeutics, Inc. | Series B | — | Mar 2021 |
 Enthera | Series A | — | Jan 2021 |
| Accent Therapeutics | Series B | $63M | Apr 2020 |
 Palleon Pharmaceuticals | Series B | $100M | Jan 2020 |
| RRibon | Series B | $75M | Jan 2019 |
| RRheostat Therapeutics | Series A | $23M | Nov 2018 |
| MMagnolia Neurosciences | Series A | $31M | Aug 2018 |
 Artios Pharma | Series B | $84M | Aug 2018 |
| Artios Pharma | Series B | — | Jan 2018 |
| EEnthera Pharmaceuticals | Seed | — | Jan 2018 |
| Palleon Pharmaceuticals | Unknown | $47.6M | Oct 2017 |
 Disarm Therapeutics | Series A | $30M | Sep 2017 |
 Virobay | Series B | $8M | Jul 2014 |
 Caribou Biosciences | Series C | $115M | — |
 Ambagon Therapeutics | Series A | $85M | — |
| Ambagon Therapeutics | Seed | — | — |
 Morphic Therapeutic | Series A | $51.5M | — |
 Faze Medicines | Series A | $81M | — |
 Syndeio Biosciences | Unknown | $90M | — |
Page 1 of 2
Top Co-Investors
Sofinnova Partners8 shared
Pfizer Ventures7 shared
Alexandria Venture Investments6 shared
MRL Ventures Fund6 shared
Takeda Ventures, Inc.4 shared
SV Health Investors4 shared
M Ventures4 shared
RA Capital Management4 shared
Bristol Myers Squibb4 shared
TPG Biotech4 shared
SR One3 shared
Surveyor Capital3 shared
Andera Partners3 shared
Arix Bioscience3 shared
Dementia Discovery Fund3 shared
Atlas Venture3 shared
Alphabet Inc.3 shared
The Column Group3 shared
Polaris Partners3 shared
Eli Lilly and Company3 shared
Last updated: 8 September 2026